As of January 1, 2019, Hawaii State Medicaid (MedQUEST) has removed requirements on fibrosis and sobriety in its guidance for hepatitis C medications. This is in alignment with recommendations from the American Association for the Study of Liver Diseases, and it will provide more people access to life-saving treatment. We will continue to work with patients, providers, and insurance plans to ensure that these new recommendations are implemented. Learn More